1292 related articles for article (PubMed ID: 16414198)
21. Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy.
Chen J; Wu Q; Yang P; Hsu HC; Mountz JD
Mol Ther; 2006 Feb; 13(2):260-9. PubMed ID: 16324888
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of recombinant adeno-associated viral vectors serotypes 1, 2, and 5 for the transduction of pancreatic and colon carcinoma cells.
Teschendorf C; Emons B; Muzyczka N; Graeven U; Schmiegel W
Anticancer Res; 2010 Jun; 30(6):1931-5. PubMed ID: 20651336
[TBL] [Abstract][Full Text] [Related]
23. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ
Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988
[TBL] [Abstract][Full Text] [Related]
24. Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain.
Wang C; Wang CM; Clark KR; Sferra TJ
Gene Ther; 2003 Aug; 10(17):1528-34. PubMed ID: 12900769
[TBL] [Abstract][Full Text] [Related]
25. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
26. Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.
Wu JQ; Zhao WH; Li Y; Zhu B; Yin KS
Virology; 2007 Nov; 368(2):309-16. PubMed ID: 17675129
[TBL] [Abstract][Full Text] [Related]
27. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
28. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
Rivière C; Danos O; Douar AM
Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
[TBL] [Abstract][Full Text] [Related]
29. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
30. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
Wu Z; Asokan A; Samulski RJ
Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
[TBL] [Abstract][Full Text] [Related]
31. Adeno-associated virus capsid serotype identification: Analytical methods development and application.
Van Vliet K; Mohiuddin Y; McClung S; Blouin V; Rolling F; Moullier P; Agbandje-McKenna M; Snyder RO
J Virol Methods; 2009 Aug; 159(2):167-77. PubMed ID: 19447508
[TBL] [Abstract][Full Text] [Related]
32. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia.
Lebherz C; Gao G; Louboutin JP; Millar J; Rader D; Wilson JM
J Gene Med; 2004 Jun; 6(6):663-72. PubMed ID: 15170737
[TBL] [Abstract][Full Text] [Related]
33. Comparative analysis of in vivo and in vitro AAV vector transduction in the neonatal mouse retina: effects of serotype and site of administration.
Pang JJ; Lauramore A; Deng WT; Li Q; Doyle TJ; Chiodo V; Li J; Hauswirth WW
Vision Res; 2008 Feb; 48(3):377-85. PubMed ID: 17950399
[TBL] [Abstract][Full Text] [Related]
34. Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1.
Iwamoto N; Watanabe A; Yamamoto M; Miyake N; Kurai T; Teramoto A; Shimada T
J Gene Med; 2009 Jun; 11(6):498-505. PubMed ID: 19338016
[TBL] [Abstract][Full Text] [Related]
35. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
36. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes.
Dane AP; Wowro SJ; Cunningham SC; Alexander IE
Gene Ther; 2013 Apr; 20(4):460-4. PubMed ID: 22895507
[TBL] [Abstract][Full Text] [Related]
37. Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells.
Stachler MD; Bartlett JS
Gene Ther; 2006 Jun; 13(11):926-31. PubMed ID: 16482202
[TBL] [Abstract][Full Text] [Related]
38. Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats.
Paterna JC; Feldon J; Büeler H
J Virol; 2004 Jul; 78(13):6808-17. PubMed ID: 15194756
[TBL] [Abstract][Full Text] [Related]
39. A CMV-actin-globin hybrid promoter improves adeno-associated viral vector gene expression in the arterial wall in vivo.
Nitta Y; Kawamoto S; Halbert C; Iwata A; Miller AD; Miyazaki J; Allen MD
J Gene Med; 2005 Oct; 7(10):1348-55. PubMed ID: 15945122
[TBL] [Abstract][Full Text] [Related]
40. Gene delivery GAD 500 autoantigen by AAV serotype 1 prevented diabetes in NOD mice: transduction efficiency do not play important roles.
Han G; Wang R; Chen G; Wang J; Xu R; Feng J; Yu M; Wu X; Qian J; Shen B; Li Y
Immunol Lett; 2008 Jan; 115(2):110-6. PubMed ID: 18045698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
